CDKN2A and melanoma: The immune escape mechanism may be triggered by the modifications in the DNA methylation pattern, as in the case of melanoma, promoter methylation in the case of PTEN, CDKN2A or ARF was observed in several melanoma patients leading to poor prognostic and cell cycle dysregulation.